Bioventus Inc (NAS:BVS)
$ 11.03 0.35 (3.28%) Market Cap: 698.13 Mil Enterprise Value: 1.08 Bil PE Ratio: 0 PB Ratio: 4.67 GF Score: 58/100

Q1 2024 Bioventus Inc Earnings Call Transcript

May 07, 2024 / 12:30PM GMT
Release Date Price: $5.12 (+28.00%)
Operator

Good day, and welcome to the Bioventus first-quarter 2024 earnings conference call. (Operator Instructions) Please note this event is being recorded.

I would now like to hand the call over to Dave Crawford, Vice President of Investor Relations. Please go ahead.

Dave Crawford
Bioventus Inc. - VP, IR & Treasurer

Thank you, Andrea, and good morning, everyone, and thanks for joining us. It is my pleasure to welcome you to the Bioventus 2024 first-quarter earnings conference call. With me this morning are Rob Claypoole, President and CEO; and Mark Singleton, Senior Vice President and CFO. Rob will begin his remarks with an update on our 2024 priorities in our business. Mark will provide detail of our first-quarter results and discuss our updated 2024 financial guidance. We will finish the call with Q&A. Our presentation for today's call is available on the investors section of our website, bioventus.com.

But before we begin, I would like to remind everyone that our remarks today contain forward-looking statements that are based on the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot